Transcatheter aortic valve implantation for high-risk patients with severe aortic stenosis: A systematic review.
暂无分享,去创建一个
Tristan D Yan | M. Ng | P. Bannon | T. Yan | C. Cao | J. Martens-Nielsen | R. Padang | M. Vallely | Christopher Cao | Paul G Bannon | Michael P Vallely | Julie Martens-Nielsen | Ratnasari Padang | Martin Ng
[1] Daniel R Wong,et al. Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients. , 2009, The Journal of thoracic and cardiovascular surgery.
[2] A. Cribier,et al. [Aortic bioprosthesis implanted percutaneously: three year follow up]. , 2007, Archives des maladies du coeur et des vaisseaux.
[3] A. Ducharme,et al. Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis. , 2007, The Journal of thoracic and cardiovascular surgery.
[4] P. Block. Transcatheter aortic valve replacement: here and now, but lots to learn. , 2009, The Journal of invasive cardiology.
[5] P. Serruys,et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[6] A. Ducharme,et al. Role of Transesophageal Echocardiography in Percutaneous Aortic Valve Replacement with the CoreValve Revalving System , 2008, Echocardiography.
[7] Ron Ree,et al. Case series: anesthesia for retrograde percutaneous aortic valve replacement — experience with the first 40 patients , 2008, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[8] A. Cheung,et al. Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[9] A. Cribier,et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. , 2006, Journal of the American College of Cardiology.
[10] D. Cokkinos,et al. Transcatheter aortic valve implantation: first Greek experience. , 2008, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.
[11] D. Hildick-Smith,et al. Percutaneous aortic valve implants under sedation: Our initial experience , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[12] R. Fish,et al. Percutaneous heart valve replacement: enthusiasm tempered. , 2004, Circulation.
[13] Assaf Bash,et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. , 2004, Journal of the American College of Cardiology.
[14] Thomas A Vassiliades,et al. The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society of Cardiovascular Angiography and Intervention (SCAI). , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[15] M. Leon,et al. Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis First Human Case Description , 2002 .
[16] P. Serruys,et al. Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve Revalving System aortic valve bioprosthesis. , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[17] Thomas Walther,et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. , 2007, Journal of the American College of Cardiology.
[18] A. Moritz,et al. The transapical approach for aortic valve implantation. , 2008, The Journal of thoracic and cardiovascular surgery.
[19] Franz Schwarz,et al. The Effect of Aortic Valve Replacement on Survival , 1982, Circulation.
[20] Volkmar Falk,et al. Minimally invasive transapical beating heart aortic valve implantation--proof of concept. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[21] Thomas Felderhoff,et al. Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study , 2006 .
[22] T. Sundt,et al. Is the European System for Cardiac Operative Risk Evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement? , 2008, The Journal of thoracic and cardiovascular surgery.
[23] Volkmar Falk,et al. Transapical minimally invasive aortic valve implantation; the initial 50 patients. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[24] D. Capodanno,et al. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. , 2009, The Journal of invasive cardiology.
[25] Y. Castier,et al. Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. , 2008, European heart journal.
[26] Lukas Altwegg,et al. Percutaneous Transarterial Aortic Valve Replacement in Selected High-Risk Patients With Aortic Stenosis , 2007, Circulation.
[27] Anson Cheung,et al. Transapical Transcatheter Aortic Valve Implantation in Humans: Initial Clinical Experience , 2006, Circulation.
[28] Alain Cribier,et al. Acute Improvement in Global and Regional Left Ventricular Systolic Function After Percutaneous Heart Valve Implantation in Patients With Symptomatic Aortic Stenosis , 2004, Circulation.
[29] Mirko Doss,et al. Transapical Minimally Invasive Aortic Valve Implantation: Multicenter Experience , 2007, Circulation.
[30] B. Astor,et al. Mortality after aortic valve replacement: results from a nationally representative database. , 2000, The Annals of thoracic surgery.
[31] M. Mack,et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. , 2008, The Annals of thoracic surgery.
[32] P. Serruys,et al. Population characteristics, treatment assignment and survival of patients with aortic stenosis referred for percutaneous valve replacement. , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[33] Philippe Ravaud,et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.
[34] Christopher E. Buller,et al. Percutaneous Aortic Valve Implantation Retrograde From the Femoral Artery , 2006, Circulation.
[35] Colin Berry,et al. Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving™ System , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[36] A. Galloway,et al. High-risk aortic valve replacement: are the outcomes as bad as predicted? , 2008, The Annals of thoracic surgery.
[37] P. Pibarot,et al. Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. , 2008, The American journal of cardiology.